BR100 Decreased By (-1.07%)
BR30 Decreased By (-1.47%)
KSE100 Decreased By (-0.89%)
KSE30 Decreased By (-1.04%)
BECO 5.57 Decreased By ▼ -0.26 (-4.46%)
BML 60.50 Increased By ▲ 2.60 (4.49%)
BOP 33.26 Decreased By ▼ -0.53 (-1.57%)
CNERGY 8.04 Decreased By ▼ -0.11 (-1.35%)
DCL 11.31 Decreased By ▼ -0.48 (-4.07%)
FCCL 53.01 Decreased By ▼ -0.48 (-0.9%)
FCSC 5.37 Decreased By ▼ -0.03 (-0.56%)
FFL 17.62 Decreased By ▼ -0.22 (-1.23%)
FNEL 1.32 Increased By ▲ 0.02 (1.54%)
HUMNL 11.15 Increased By ▲ 0.04 (0.36%)
KEL 7.87 Decreased By ▼ -0.15 (-1.87%)
KOSM 5.34 Decreased By ▼ -0.11 (-2.02%)
MLCF 85.15 Decreased By ▼ -2.25 (-2.57%)
NBP 181.75 Decreased By ▼ -2.49 (-1.35%)
PACE 11.55 Decreased By ▼ -0.07 (-0.6%)
PAEL 39.50 Decreased By ▼ -0.75 (-1.86%)
PIAHCLA 25.61 Decreased By ▼ -0.51 (-1.95%)
PIBTL 17.15 Increased By ▲ 0.01 (0.06%)
PPL 224.75 Decreased By ▼ -3.98 (-1.74%)
PRL 34.30 Decreased By ▼ -0.19 (-0.55%)
PTC 65.00 Decreased By ▼ -2.54 (-3.76%)
SEARL 89.81 Decreased By ▼ -1.12 (-1.23%)
SSGC 26.37 Decreased By ▼ -0.46 (-1.71%)
TELE 8.43 Decreased By ▼ -0.10 (-1.17%)
THCCL 69.18 Increased By ▲ 3.04 (4.6%)
TPLP 10.33 Increased By ▲ 1.00 (10.72%)
TREET 24.22 Decreased By ▼ -0.29 (-1.18%)
TRG 69.55 Decreased By ▼ -2.06 (-2.88%)
WAVES 11.03 Increased By ▲ 0.05 (0.46%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
اردو
Android App
Print Edition Dollar to PKR
Budget 2026-27 Iran-US war Petrol Prices Gold Rates Podcasts PSX Notices
Markets

Drugmaker AstraZeneca profit jumps as it expands in US

  • Profit after tax stood at $2.53 billion in the three months to the end of September
Published November 6, 2025 Updated November 6, 2025 12:52pm
Save
1 min
comment
By AFP
Add BRecorder as a trusted
source on Google
Google Preferred Source

LONDON: British pharmaceutical giant AstraZeneca on Thursday said its net profit jumped 77 percent in the third quarter as the group expands its operations in the United States.

Profit after tax stood at $2.53 billion in the three months to the end of September, up from $1.43 billion one year earlier, AstraZeneca said in a statement.

AstraZeneca

Comments

Comments are closed for this article.

More Stories

Browse all stories